The L1210 radioimmune assay for detecting circulating immune complexes

Area of Science:

• Immunology
• Biochemistry
• Medical Diagnostics

Background:

• Circulating immune complexes (CICs) are implicated in various autoimmune and infectious diseases.
• Accurate detection and quantification of CICs are crucial for diagnosis and monitoring disease progression.
• Existing assays for CICs have limitations, including dependence on complement fixation.

Purpose of the Study:

• To develop and validate a novel radioimmunoassay for detecting and quantifying CICs.
• To utilize the L1210 murine leukemia cell line for CIC detection via its Fc receptor.
• To assess the assay's sensitivity, specificity, and applicability across different species.

Main Methods:

• Development of a radioimmunoassay employing L1210 murine leukemia cells.
• Binding of CICs to the L1210 cell's Fc receptor.
• Quantification of bound CICs using an Iodine-125 labeled anti-IgG antibody.
• Standard curve generation using heat-aggregated IgG (AIgG).

Main Results:

• The assay effectively binds aggregated IgG (AIgG) but not native 7S IgG from human, canine, and murine species to L1210 cells.
• The assay successfully differentiated sera from healthy individuals and those with CIC-associated diseases (e.g., lupus erythematosus, hepatitis B).
• The L1210 radioimmunoassay demonstrated a sensitivity of 5 micrograms of CICs per milliliter of serum across all tested species.

Conclusions:

• A sensitive and specific radioimmunoassay for CIC detection has been established using L1210 cells.
• This assay offers an advantage by detecting CICs independently of their complement-fixing properties.
• The L1210 radioimmunoassay provides a valuable tool for diagnosing and studying diseases associated with CICs in multiple species.